Systemic GHK-Cu administration in aged mice has produced intriguing effects on multiple organ systems, including improved dermal thickness and collagen density, enhanced hepatic regenerative capacity following partial hepatectomy, and increased bone density measurements
Safety considerations BPC-157, TB-500, and GHK-Cu are not FDA-approved for human use
Example: 10 mg 2 mL = 5 mg/mL Example: 5 mg 1 mL = 5 mg/mL (same concentration, half the volume) The syringe-unit bridge: Insulin syringes are marked in "units", not millilitres
Xenotransplantation 14, 288297
Beyond gastric applications, BPC-157 shows therapeutic potential for lesions throughout the gastrointestinal tract, including esophagus, duodenum, small intestine, colon, liver, and pancreas
While some FDAapproved peptides are used for legitimate medical purposes, many peptides sold on social media may be unregulated and harmful.